MedTrace Logo

Propofol-induced EEG Changes in Hypoxic Brain Injury

NCT03485781 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2020-03-25

No results posted yet for this study

Summary

PROPEA3 is a prospective observational study investigating the recovery of propofol-induced EEG slow-wave activity and its association with neurological outcome after cardiac arrest.

Conditions

  • Hypoxic-Ischemic Encephalopathy
  • Cardiac Arrest

Sponsors & Collaborators

  • Oulu University Hospital

    collaborator OTHER

  • Helsinki University Central Hospital

    collaborator OTHER

  • Cerenion Oy

    collaborator INDUSTRY

  • University of Oulu

    lead OTHER

Principal Investigators

  • Jukka Kortelainen, MD, PhD · University of Oulu

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-12
Primary Completion
2019-07-10
Completion
2019-07-10

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03485781 on ClinicalTrials.gov